Iovance Biotherapeutics, Inc.

Q3 2018 vs. Q4 2020 13F Holders

Period
Q3 2018
Q4 2020
Num holders
141
298
Total reported value, excl. options
$1.03 B
$6.91 B
Total shares, excl. options
91,888,617
148,963,930
Manager Q3 2018
Shares 		Q4 2020
Shares 		Diff Chg %